Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas
Status:
Completed
Trial end date:
2003-10-03
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Gemcitabine may
make tumor cells more sensitive to radiation therapy. Combining chemotherapy with radiation
therapy after surgery may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine with radiation
therapy in treating patients who have undergone surgery to remove cancer of the pancreas.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest Baptist Health Wake Forest University Health Sciences